 Exophthalmos
"Exophthalmos" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.
| Descriptor ID |
D005094
|
| MeSH Number(s) |
C11.675.349
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Exophthalmos".
Below are MeSH descriptors whose meaning is more specific than "Exophthalmos".
This graph shows the total number of publications written about "Exophthalmos" by people in this website by year, and whether "Exophthalmos" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 | | 2016 | 1 | 1 | 2 | | 2017 | 0 | 1 | 1 | | 2020 | 1 | 0 | 1 | | 2021 | 2 | 0 | 2 | | 2022 | 2 | 0 | 2 | | 2023 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Exophthalmos" by people in Profiles.
-
Douglas RS, Couch S, Wester ST, Fowler BT, Liu CY, Subramanian PS, Tang R, Nguyen QT, Maamari RN, Ugradar S, Hsu K, Karon M, Stan MN. Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity. J Clin Endocrinol Metab. 2023 Dec 21; 109(1):25-35.
-
Kahaly GJ, Dolman PJ, Wolf J, Giers BC, Elflein HM, Jain AP, Srinivasan A, Hadjiiski L, Jordan D, Bradley EA, Stan MN, Eckstein A, Pitz S, Vorl?nder C, Wester ST, Nguyen J, Tucker N, Sales-Sanz M, Feldon SE, Nelson CC, Hardy I, Abia-Serrano M, Tedeschi P, Janes JM, Xu J, Vue P, Macias WL, Douglas RS. Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease. J Clin Endocrinol Metab. 2023 Nov 17; 108(12):3122-3134.
-
Subramanian PS, Cho RI, Kahana A. Efficacy of teprotumumab therapy in patients with long-duration thyroid eye disease. Curr Opin Ophthalmol. 2023 Nov 01; 34(6):487-492.
-
Ting MA, Ozzello DJ, Topilow NJ, Yoon JS, Liu CY, Korn BS, Kikkawa DO. Differential effects of teprotumumab treatment based on fat-to-muscle ratio in patients with thyroid eye disease. Orbit. 2023 Aug; 42(4):418-425.
-
Douglas RS, Dailey R, Subramanian PS, Barbesino G, Ugradar S, Batten R, Qadeer RA, Cameron C. Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison. JAMA Ophthalmol. 2022 04 01; 140(4):328-335.
-
Kim M, Levitt AE, Latchmansingh KJ, Tse DT, Choi CJ. Ocular Adnexal MALT Lymphoma in Association With Rosai-Dorfman Disease in a Child. Ophthalmic Plast Reconstr Surg. 2021 Sep-Oct 01; 37(5):e158-e160.
-
Hoang TT, Tran HMD, Van Truong B, Subramanian P. Presentation of High-Flow Cerebral Proliferative Angiopathy With Adie's-Like Pupil and Proptosis. J Neuroophthalmol. 2021 Jun 01; 41(2):e184-e185.
-
Ozzello DJ, Dallalzadeh LO, Liu CY. Teprotumumab for chronic thyroid eye disease. Orbit. 2022 Oct; 41(5):539-546.
-
Ram PK, Singh SK, Kumari P, Srivastava M, Sudan V, Pandey RP, Garg SK. Role of cytokines in the clinical manifestation of exophthalmia in newborn calves with tropical theileriosis. Parasite Immunol. 2020 10; 42(10):e12761.
-
Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS. Teprotumumab for Thyroid-Associated Ophthalmopathy. N Engl J Med. 2017 05 04; 376(18):1748-1761.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|